Home
Data
Calendar
Blog
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.00 | NA | NA | 0.00 | NA | NA | NA | |
| Shares Outstanding | NA | NA | NA | NA | NA | 96.86 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| dei: Entity Common Stock Shares Outstanding | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | NA | NA | NA | NA | NA | 96.70 | NA | NA | NA | 94.33 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | NA | NA | NA | NA | NA | 96.70 | NA | NA | NA | 94.33 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | NA | NA | NA | NA | NA | NA | 96.34 | NA | 95.41 | 94.33 | 93.43 | NA | 86.89 | 79.30 | 75.89 | NA | 66.93 | 65.21 | 64.92 | NA | 54.19 | 53.13 | 52.76 | NA | 41.43 | 41.41 | 41.39 | NA | 32.09 | 28.87 | 28.78 | NA | 28.65 | 23.92 | 20.35 | NA | 1.26 | 1.24 | 1.21 | NA | 1.17 | NA | NA | |
| Earnings Per Share Basic | -0.46 | -0.54 | -0.19 | -0.58 | -0.86 | -0.79 | -0.68 | -0.72 | -0.45 | -0.58 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Diluted | -0.46 | -0.54 | -0.19 | -0.58 | -0.86 | -0.79 | -0.68 | -0.72 | -0.45 | -0.58 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic And Diluted | NA | NA | NA | NA | NA | NA | -0.68 | -0.72 | -0.45 | -0.58 | -0.48 | -0.61 | -0.68 | -0.35 | -0.44 | -0.37 | -0.40 | -0.36 | -0.30 | -0.25 | -0.31 | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 | -0.24 | -0.21 | -0.27 | -0.29 | -0.29 | -0.26 | -0.24 | -0.33 | -0.34 | -0.29 | -4.81 | -4.46 | -2.92 | -3.51 | -3.51 | -2.58 | -3.43 |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 1.94 | 0.93 | 58.98 | 44.36 | 14.98 | 18.55 | 18.41 | 17.07 | 14.22 | 13.41 | 11.14 | 15.90 | 7.56 | 5.46 | 2.52 | 2.80 | 2.43 | 2.82 | 2.63 | 1.66 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.32 | 1.08 | 1.03 | 0.33 | 0.00 | 0.00 | 0.21 | 0.29 | 0.47 | 0.64 | 0.53 | 1.08 | 0.42 | |
| Revenues | 1.94 | 0.93 | 58.98 | 44.36 | 14.98 | 18.55 | 18.41 | 17.07 | 14.22 | 13.41 | 11.14 | 15.90 | 7.56 | 5.46 | 2.52 | 2.80 | 2.43 | 2.82 | 2.63 | 1.66 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.32 | 1.08 | 1.03 | 0.33 | 0.00 | 0.00 | 0.21 | 0.29 | 0.47 | 0.64 | 0.53 | 1.08 | 0.42 | |
| Operating Expenses | 53.22 | 63.50 | 87.57 | 108.78 | 101.37 | 101.66 | 92.88 | 86.45 | 68.85 | 60.19 | 57.35 | 49.30 | 39.05 | 34.17 | 37.01 | 31.88 | 29.55 | 26.90 | 23.08 | 18.40 | 17.72 | 20.63 | 15.08 | 13.27 | 11.37 | 10.60 | 11.00 | 8.68 | 9.41 | 9.03 | 9.24 | 7.99 | 7.35 | 7.55 | 6.94 | 4.90 | 5.36 | 4.56 | 3.83 | 4.69 | 4.18 | 3.82 | 3.54 | |
| Research And Development Expense | 34.27 | 40.88 | 65.63 | 87.19 | 79.82 | 81.31 | 72.14 | 69.52 | 53.13 | 48.02 | 44.85 | 38.98 | 30.69 | 26.67 | 29.28 | 25.21 | 23.20 | 21.63 | 17.73 | 14.10 | 13.64 | 16.82 | 11.48 | 9.89 | 8.58 | 7.93 | 7.97 | 6.23 | 6.80 | 6.78 | 6.64 | 5.43 | 5.00 | 4.86 | 4.52 | 3.03 | 3.38 | 3.07 | 2.53 | 3.40 | 3.31 | NA | NA | |
| General And Administrative Expense | 18.95 | 22.62 | 21.94 | 21.58 | 21.55 | 20.35 | 20.74 | 16.94 | 15.72 | 12.17 | 12.50 | 10.31 | 8.35 | 7.50 | 7.73 | 6.67 | 6.35 | 5.27 | 5.35 | 4.31 | 4.08 | 3.82 | 3.60 | 3.38 | 2.79 | 2.67 | 3.03 | 2.45 | 2.61 | 2.25 | 2.60 | 2.56 | 2.35 | 2.69 | 2.42 | 1.87 | 1.98 | 1.49 | 1.30 | 1.28 | 0.86 | NA | NA | |
| Operating Income Loss | -51.28 | -62.56 | -28.59 | -64.42 | -86.39 | -83.11 | -74.47 | -69.38 | -54.62 | -46.78 | -46.21 | -33.40 | -31.49 | -28.71 | -34.49 | -29.08 | -27.12 | -24.08 | -20.45 | -16.74 | -16.69 | -19.61 | -14.05 | -12.24 | -10.34 | -9.57 | -9.97 | -7.65 | -8.39 | -8.00 | -7.92 | -6.91 | -6.33 | -7.22 | -6.94 | -4.90 | -5.15 | -4.27 | -3.36 | -4.04 | -3.65 | NA | NA | |
| Allocated Share Based Compensation Expense | 10.10 | 12.90 | 10.98 | 19.39 | 19.47 | 20.54 | 19.33 | 14.59 | 13.54 | 13.25 | 12.98 | 8.76 | 7.84 | 7.24 | 6.91 | 4.58 | 4.57 | 4.39 | 3.87 | 1.78 | 1.64 | 1.49 | 1.38 | 0.90 | 0.87 | 0.97 | 0.87 | 0.82 | 0.78 | 0.79 | 0.80 | 0.48 | 0.57 | 0.74 | 0.87 | 0.39 | 0.98 | 0.11 | 0.07 | NA | NA | NA | NA | |
| Profit Loss | -45.17 | -52.76 | -18.88 | -56.36 | -83.56 | -76.11 | -65.69 | -68.62 | -43.31 | -55.13 | -45.09 | -53.11 | -58.68 | -28.07 | -33.52 | -28.30 | -26.61 | -23.48 | -19.76 | -16.03 | -16.78 | -19.65 | -14.13 | -12.50 | -10.68 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Income Loss | -45.17 | -52.76 | -18.88 | -56.36 | -83.56 | -76.11 | -65.69 | -68.62 | -43.31 | -55.13 | -45.09 | -53.11 | -58.68 | -28.07 | -33.52 | -28.30 | -26.61 | -23.48 | -19.76 | -16.03 | -16.78 | -19.65 | -14.13 | -12.50 | -10.68 | -9.64 | -10.13 | -7.94 | -8.74 | -8.41 | -8.38 | -7.45 | -6.89 | -7.78 | -6.98 | -5.74 | -6.07 | -5.53 | -3.55 | -4.16 | -4.11 | -2.74 | -3.23 |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 543.79 | 584.76 | 630.34 | 705.56 | 749.35 | 807.06 | 858.39 | 921.46 | 984.57 | 1015.67 | 1045.96 | 622.46 | 626.44 | 653.59 | 321.89 | 302.27 | 340.21 | 199.88 | 220.87 | 213.03 | 219.95 | 83.16 | 93.42 | 105.29 | 72.67 | 73.95 | 85.33 | 95.05 | 49.30 | 49.18 | 58.70 | 67.96 | 76.40 | 83.48 | 49.65 | 55.58 | 23.04 | NA | NA | 11.08 | NA | NA | NA | |
| Liabilities And Stockholders Equity | 543.79 | 584.76 | 630.34 | 705.56 | 749.35 | 807.06 | 858.39 | 921.46 | 984.57 | 1015.67 | 1045.96 | 622.46 | 626.44 | 653.59 | 321.89 | 302.27 | 340.21 | 199.88 | 220.87 | 213.03 | 219.95 | 83.16 | 93.42 | 105.29 | 72.67 | 73.95 | 85.33 | 95.05 | 49.30 | 49.18 | 58.70 | 67.96 | 76.40 | 83.48 | 49.65 | 55.58 | 23.04 | NA | NA | 11.08 | NA | NA | NA | |
| Stockholders Equity | 402.78 | 437.75 | 477.47 | 483.94 | 518.00 | 580.48 | 633.39 | 678.84 | 730.33 | 752.07 | 790.10 | 384.44 | 424.37 | 474.11 | 219.22 | 244.76 | 268.04 | 127.53 | 145.84 | 160.47 | 173.93 | 51.83 | 65.00 | 77.19 | 45.75 | 55.21 | 63.86 | 73.15 | 25.37 | 23.13 | 30.73 | 38.04 | 44.99 | 51.07 | 45.18 | 50.85 | -66.40 | NA | NA | -52.83 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 364.17 | 392.18 | 437.89 | 502.07 | 535.33 | 599.16 | 599.08 | 633.41 | 693.71 | 713.27 | 804.32 | 494.32 | 496.78 | 540.23 | 208.25 | 227.09 | 305.63 | 165.18 | 186.43 | 205.20 | 213.93 | 80.03 | 90.62 | 102.60 | 70.04 | 71.86 | 83.44 | 93.32 | 47.40 | 47.09 | 56.57 | 65.65 | 74.19 | 81.57 | 48.26 | 54.65 | 19.39 | NA | NA | 9.79 | NA | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 33.33 | 46.80 | 42.02 | 61.33 | 82.09 | 55.27 | 64.74 | 133.58 | 129.18 | 76.65 | 106.41 | 167.35 | 349.13 | 433.07 | 83.37 | 99.81 | 249.59 | 71.44 | 183.03 | 190.51 | 183.25 | 36.16 | 32.91 | 88.95 | 43.23 | 31.06 | 40.61 | 88.61 | 37.10 | 35.87 | 39.49 | 64.81 | 72.86 | 81.18 | 47.88 | 54.04 | 19.08 | 3.40 | 4.65 | 9.09 | 5.46 | NA | NA | |
| Short Term Investments | NA | NA | NA | 374.89 | NA | NA | NA | 482.33 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 39.95 | 41.69 | 3.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Accounts Receivable Net Current | 1.54 | 2.83 | 13.50 | 38.48 | 10.22 | 13.13 | 13.85 | 8.68 | 7.31 | 10.30 | 6.95 | 5.51 | 3.24 | NA | NA | NA | NA | NA | 0.50 | 0.50 | NA | NA | 0.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Prepaid Expense And Other Assets Current | 12.90 | 11.41 | 15.49 | 27.37 | 19.97 | 17.18 | 11.45 | 8.83 | 7.70 | 7.37 | 7.24 | 5.89 | 4.73 | 5.10 | 4.96 | 5.66 | 2.81 | 3.17 | 2.90 | 3.69 | 2.24 | 2.02 | 1.49 | 1.65 | 0.82 | 0.85 | 1.14 | 1.21 | 0.78 | 1.16 | 0.95 | 0.84 | 0.48 | 0.40 | 0.38 | 0.61 | 0.30 | NA | NA | 0.71 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | NA | NA | NA | 140.40 | NA | NA | NA | 108.47 | NA | NA | NA | 43.40 | NA | NA | NA | 19.94 | NA | NA | NA | 11.45 | NA | NA | NA | 7.69 | NA | NA | NA | 5.78 | NA | NA | NA | 5.63 | NA | NA | NA | 3.11 | NA | NA | NA | 2.91 | NA | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | NA | NA | 30.38 | NA | NA | NA | 16.95 | NA | NA | NA | 11.10 | NA | NA | NA | 8.52 | NA | NA | NA | 6.33 | NA | NA | NA | 5.14 | NA | NA | NA | 4.20 | NA | NA | NA | 3.47 | NA | NA | NA | 2.30 | NA | NA | NA | 1.75 | NA | NA | NA | |
| Property Plant And Equipment Net | 101.71 | 106.33 | 108.59 | 110.02 | 109.12 | 103.12 | 97.86 | 91.53 | 74.62 | 59.21 | 47.95 | 32.31 | 20.71 | 15.93 | 11.90 | 11.42 | 9.65 | 9.22 | 8.40 | 5.12 | 3.80 | 2.89 | 2.65 | 2.55 | 2.49 | 1.95 | 1.75 | 1.58 | 1.75 | 1.94 | 1.99 | 2.16 | 2.07 | 1.77 | 1.26 | 0.81 | 0.79 | NA | NA | 1.16 | NA | NA | NA | |
| Long Term Investments | NA | 7.29 | 3.91 | 4.94 | 13.94 | 11.93 | 67.94 | 100.66 | 124.88 | 149.50 | 98.28 | NA | 13.23 | NA | 16.14 | 39.44 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Assets Noncurrent | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | NA | NA | 0.53 | NA | NA | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 41.33 | 44.69 | 48.65 | 114.05 | 103.94 | 91.52 | 77.91 | 81.28 | 91.88 | 105.60 | 94.58 | 85.56 | 54.20 | 45.32 | 24.92 | 27.81 | 40.59 | 29.42 | 29.14 | 27.26 | 22.67 | 16.27 | 12.59 | 11.05 | 9.72 | 8.05 | 16.90 | 15.19 | 14.68 | 14.33 | 13.89 | 13.44 | 12.60 | 11.31 | 4.35 | 4.60 | 9.49 | NA | NA | 4.85 | NA | NA | NA | |
| Accounts Payable Current | 5.71 | 7.51 | 9.86 | 8.27 | 9.59 | 8.42 | 11.44 | 8.61 | 6.44 | 5.77 | 9.00 | 6.28 | 3.72 | 13.56 | 5.17 | 5.82 | 5.71 | 5.41 | 5.37 | 4.21 | 5.24 | 3.51 | 2.16 | 1.68 | 2.20 | 1.18 | 2.47 | 0.93 | 1.20 | 2.00 | 1.98 | 1.00 | 1.28 | 1.51 | 1.33 | 0.68 | NA | NA | NA | 1.23 | NA | NA | NA | |
| Other Accrued Liabilities Current | 8.63 | 8.11 | 10.23 | 19.18 | 18.90 | 12.29 | 13.03 | 11.71 | 10.80 | 7.34 | 5.74 | 5.50 | 3.81 | 3.15 | 3.24 | 3.39 | 4.45 | 2.94 | 3.59 | 3.26 | 2.63 | 2.98 | 3.40 | 2.17 | 1.53 | 1.94 | 1.75 | 1.41 | 1.27 | 0.66 | 0.75 | 1.00 | 0.78 | 1.08 | NA | 0.79 | NA | NA | NA | NA | NA | NA | NA | |
| Accrued Liabilities Current | 28.54 | 29.47 | 31.51 | 53.93 | 50.15 | 40.52 | 35.11 | 42.41 | 54.00 | 25.74 | 20.93 | 15.56 | 14.78 | 11.62 | 11.77 | 14.70 | 13.84 | 9.83 | 9.95 | 10.93 | 9.64 | 8.38 | 7.44 | 7.25 | 5.41 | 4.77 | 4.70 | 3.96 | 3.34 | 2.35 | 2.04 | 2.44 | 2.32 | 2.49 | 1.64 | 2.04 | NA | NA | NA | 1.04 | NA | NA | NA | |
| Contract With Customer Liability Current | 1.11 | 1.93 | 1.74 | 42.23 | 35.24 | 33.66 | 22.57 | 21.48 | 23.55 | 23.03 | 21.03 | 21.14 | 17.12 | 14.63 | 2.92 | 2.79 | 3.37 | 5.05 | 6.58 | 7.59 | 3.25 | 1.78 | NA | 2.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | 98.98 | 100.56 | 102.07 | 103.71 | 105.16 | 106.59 | 107.94 | 109.24 | 104.36 | 105.41 | 106.51 | 93.94 | 83.16 | 78.68 | 73.83 | 25.23 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 402.78 | 437.75 | 477.47 | 483.94 | 518.00 | 580.48 | 633.39 | 678.84 | 730.33 | 752.07 | 790.10 | 384.44 | 424.37 | 474.11 | 219.22 | 244.76 | 268.04 | 127.53 | 145.84 | 160.47 | 173.93 | 51.83 | 65.00 | 77.19 | 45.75 | 55.21 | 63.86 | 73.15 | 25.37 | 23.13 | 30.73 | 38.04 | 44.99 | 51.07 | 45.18 | 50.85 | -66.40 | NA | NA | -52.83 | NA | NA | NA | |
| Common Stock Value | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.00 | NA | NA | 0.00 | NA | NA | NA | |
| Additional Paid In Capital | 1570.78 | 1560.68 | 1547.70 | 1536.50 | 1515.60 | 1494.64 | 1470.92 | 1448.58 | 1430.77 | 1409.21 | 1392.28 | 941.22 | 927.78 | 918.53 | 636.06 | 628.20 | 623.16 | 456.00 | 450.93 | 445.80 | 443.24 | 304.37 | 297.88 | 295.93 | 252.02 | 250.82 | 249.82 | 248.96 | NA | NA | NA | NA | 179.90 | 179.10 | 138.65 | 137.34 | 14.37 | NA | NA | 12.79 | NA | NA | NA | |
| Retained Earnings Accumulated Deficit | -1167.61 | -1122.44 | -1069.68 | -1050.80 | -994.44 | -910.88 | -834.77 | -769.08 | -700.46 | -657.15 | -602.02 | -556.93 | -503.82 | -445.14 | -417.06 | -383.55 | -355.24 | -328.63 | -305.16 | -285.40 | -269.37 | -252.59 | -232.93 | -218.80 | -206.30 | -195.62 | -185.97 | -175.85 | -167.91 | -159.17 | -150.76 | -142.38 | -134.94 | -128.05 | NA | -86.51 | NA | NA | NA | NA | NA | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0.50 | -0.59 | -0.65 | -1.85 | -3.25 | -3.38 | -2.85 | -0.76 | -0.07 | -0.09 | -0.26 | 0.07 | 0.31 | 0.62 | 0.14 | 0.02 | 0.05 | 0.09 | NA | -0.00 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 | -0.04 | -0.03 | -0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 10.10 | 12.90 | 10.98 | NA | 19.47 | 20.54 | 19.33 | NA | 13.54 | 13.25 | 12.98 | NA | 7.84 | 7.24 | 6.91 | NA | 4.57 | 4.39 | 3.87 | NA | 1.64 | 1.49 | 1.38 | NA | 0.87 | 0.97 | 0.87 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -38.27 | -28.49 | -28.86 | -75.39 | -55.05 | -53.16 | -64.61 | -70.29 | -33.38 | -32.11 | -27.10 | -20.66 | -30.73 | 38.84 | -26.67 | -25.54 | -19.84 | -20.31 | -17.49 | -11.02 | -3.56 | -11.52 | -12.55 | -10.72 | -9.77 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Cash Provided By Used In Investing Activities | 24.80 | 33.17 | 9.34 | 53.11 | 80.38 | 40.29 | -7.03 | 71.28 | 77.96 | -1.37 | -471.89 | -166.03 | -54.14 | 35.32 | 23.77 | -110.52 | 36.29 | -91.98 | 8.75 | 16.38 | 13.28 | 13.72 | -43.84 | 13.20 | 13.64 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Cash Provided By Used In Financing Activities | 0.00 | 0.06 | 0.21 | 1.52 | 1.49 | 3.41 | 2.80 | 3.42 | 7.94 | 3.72 | 438.05 | 4.91 | 0.93 | 275.55 | 1.45 | -13.72 | 161.71 | 0.69 | 1.26 | 1.90 | 137.37 | 1.16 | 0.35 | 43.24 | 8.30 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -38.27 | -28.49 | -28.86 | -75.39 | -55.05 | -53.16 | -64.61 | -70.29 | -33.38 | -32.11 | -27.10 | -20.66 | -30.73 | 38.84 | -26.67 | -25.54 | -19.84 | -20.31 | -17.49 | -11.02 | -3.56 | -11.52 | -12.55 | -10.72 | -9.77 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Income Loss | -45.17 | -52.76 | -18.88 | -56.36 | -83.56 | -76.11 | -65.69 | -68.62 | -43.31 | -55.13 | -45.09 | -53.11 | -58.68 | -28.07 | -33.52 | -28.30 | -26.61 | -23.48 | -19.76 | -16.03 | -16.78 | -19.65 | -14.13 | -12.50 | -10.68 | -9.64 | -10.13 | -7.94 | -8.74 | -8.41 | -8.38 | -7.45 | -6.89 | -7.78 | -6.98 | -5.74 | -6.07 | -5.53 | -3.55 | -4.16 | -4.11 | -2.74 | -3.23 | |
| Profit Loss | -45.17 | -52.76 | -18.88 | -56.36 | -83.56 | -76.11 | -65.69 | -68.62 | -43.31 | -55.13 | -45.09 | -53.11 | -58.68 | -28.07 | -33.52 | -28.30 | -26.61 | -23.48 | -19.76 | -16.03 | -16.78 | -19.65 | -14.13 | -12.50 | -10.68 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Depreciation Depletion And Amortization | 4.74 | 4.47 | 4.19 | 4.84 | 3.19 | 2.96 | 2.76 | 2.21 | 1.52 | 1.17 | 0.96 | 0.86 | 0.77 | 0.75 | 0.70 | 0.62 | 0.59 | 0.54 | 0.44 | 0.33 | 0.31 | 0.28 | 0.29 | 0.29 | 0.24 | 0.23 | 0.21 | 0.20 | 0.22 | 0.23 | 0.23 | 0.21 | 0.19 | 0.16 | 0.12 | 0.13 | 0.14 | 0.14 | 0.16 | 0.16 | NA | NA | NA | |
| Increase Decrease In Accounts Receivable | -1.30 | -10.67 | -24.98 | 28.26 | -2.90 | -0.72 | 5.17 | 1.36 | -2.99 | 3.36 | 1.43 | 2.27 | 1.53 | NA | NA | 0.00 | 0.00 | NA | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 24.80 | 33.17 | 9.34 | 53.11 | 80.38 | 40.29 | -7.03 | 71.28 | 77.96 | -1.37 | -471.89 | -166.03 | -54.14 | 35.32 | 23.77 | -110.52 | 36.29 | -91.98 | 8.75 | 16.38 | 13.28 | 13.72 | -43.84 | 13.20 | 13.64 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Payments To Acquire Property Plant And Equipment | 0.56 | 2.20 | 3.21 | 6.68 | 8.68 | 10.13 | 10.08 | 18.37 | 14.73 | 13.62 | 3.98 | 2.27 | 0.95 | 0.64 | 1.07 | 2.59 | 1.26 | 1.79 | 1.75 | 1.12 | 0.72 | 0.28 | 0.18 | 0.80 | 0.36 | 0.41 | 0.15 | 0.04 | 0.03 | 0.21 | 0.18 | 0.18 | 0.66 | 0.21 | 0.40 | 0.15 | 0.02 | 0.06 | 0.01 | 0.29 | NA | NA | NA | |
| Payments To Acquire Investments | 102.13 | 92.26 | 114.45 | 107.10 | 101.58 | 63.95 | 132.17 | 173.45 | 165.47 | 99.34 | 529.91 | 185.01 | NA | NA | NA | 142.68 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 0.00 | 0.06 | 0.21 | 1.52 | 1.49 | 3.41 | 2.80 | 3.42 | 7.94 | 3.72 | 438.05 | 4.91 | 0.93 | 275.55 | 1.45 | -13.72 | 161.71 | 0.69 | 1.26 | 1.90 | 137.37 | 1.16 | 0.35 | 43.24 | 8.30 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1.94 | 0.93 | 58.98 | 44.36 | 14.98 | 18.55 | 18.41 | 17.07 | 14.22 | 13.41 | 11.14 | 15.90 | 7.56 | 5.46 | 2.52 | 2.80 | 2.43 | 2.82 | 2.63 | 1.66 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.32 | 1.08 | 1.03 | 0.33 | 0.00 | 0.00 | 0.21 | 0.29 | 0.47 | 0.64 | 0.53 | 1.08 | 0.42 | |
| Janssen Biotech Inc | 0.00 | 0.00 | 52.30 | 31.40 | 14.20 | 18.10 | 15.90 | 13.00 | 11.20 | 10.90 | 8.60 | 7.70 | 5.60 | 3.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd | 1.90 | 0.90 | 6.70 | 12.90 | 0.80 | 0.40 | 2.50 | 4.00 | 3.00 | 2.50 | 2.50 | 8.10 | 1.90 | 2.00 | 2.50 | 2.80 | 2.40 | 2.50 | 1.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Janssen Biotech Inc, Research And Development Expense | 0.00 | 0.00 | 11.10 | NA | 10.00 | 11.40 | 9.80 | 8.50 | 7.10 | 7.10 | 6.80 | 6.20 | 2.40 | 1.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Janssen Biotech Inc, Upfront Fee And Equity Premium | 0.00 | 0.00 | 31.20 | 6.00 | 4.20 | 6.70 | 6.10 | 4.50 | 4.10 | 3.80 | 1.80 | 1.50 | 3.20 | 1.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Research Services, Collaborative Arrangement | NA | NA | NA | NA | NA | NA | 1.30 | 2.00 | 1.50 | 1.30 | 1.30 | 1.40 | 1.30 | 1.30 | 1.70 | 1.90 | 1.60 | 1.70 | 12.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Upfront Fee, Collaborative Arrangement | NA | NA | NA | -0.10 | 0.20 | 0.20 | 1.30 | 2.00 | 1.50 | 1.20 | 1.20 | 0.60 | 0.60 | 0.70 | 0.80 | 0.90 | 0.80 | 0.80 | 6.40 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Ono Letter Agreement | NA | NA | NA | 0.50 | 0.60 | 0.20 | 1.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Collaborative Arrangement | NA | NA | 2.50 | NA | NA | NA | NA | NA | 3.00 | 2.50 | NA | NA | NA | NA | NA | NA | 2.40 | 2.50 | 1.60 | 0.60 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Commercial Option Exercise | 0.00 | 9.99 | 0.01 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 1.94 | 0.93 | 58.98 | 44.36 | 14.98 | 18.55 | 18.41 | 17.07 | 14.22 | 13.41 | 11.14 | 15.90 | 7.56 | 5.46 | 2.52 | 2.80 | 2.43 | 2.82 | 2.63 | 1.66 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.32 | 1.08 | 1.03 | 0.33 | 0.00 | 0.00 | 0.21 | 0.29 | 0.47 | 0.64 | 0.53 | 1.08 | 0.42 | |
| Janssen Biotech Inc | 0.00 | 0.00 | 52.30 | 31.40 | 14.20 | 18.10 | 15.90 | 13.00 | 11.20 | 10.90 | 8.60 | 7.70 | 5.60 | 3.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd | 1.90 | 0.90 | 6.70 | 12.90 | 0.80 | 0.40 | 2.50 | 4.00 | 3.00 | 2.50 | 2.50 | 8.10 | 1.90 | 2.00 | 2.50 | 2.80 | 2.40 | 2.50 | 1.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Janssen Biotech Inc, Research And Development Expense | 0.00 | 0.00 | 11.10 | NA | 10.00 | 11.40 | 9.80 | 8.50 | 7.10 | 7.10 | 6.80 | 6.20 | 2.40 | 1.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Janssen Biotech Inc, Upfront Fee And Equity Premium | 0.00 | 0.00 | 31.20 | 6.00 | 4.20 | 6.70 | 6.10 | 4.50 | 4.10 | 3.80 | 1.80 | 1.50 | 3.20 | 1.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Research Services, Collaborative Arrangement | NA | NA | NA | NA | NA | NA | 1.30 | 2.00 | 1.50 | 1.30 | 1.30 | 1.40 | 1.30 | 1.30 | 1.70 | 1.90 | 1.60 | 1.70 | 12.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Upfront Fee, Collaborative Arrangement | NA | NA | NA | -0.10 | 0.20 | 0.20 | 1.30 | 2.00 | 1.50 | 1.20 | 1.20 | 0.60 | 0.60 | 0.70 | 0.80 | 0.90 | 0.80 | 0.80 | 6.40 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Ono Letter Agreement | NA | NA | NA | 0.50 | 0.60 | 0.20 | 1.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ono Pharmaceutical Company Ltd, Collaborative Arrangement | NA | NA | 2.50 | NA | NA | NA | NA | NA | 3.00 | 2.50 | NA | NA | NA | NA | NA | NA | 2.40 | 2.50 | 1.60 | 0.60 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Commercial Option Exercise | 0.00 | 9.99 | 0.01 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
